# Constipation on Ozempic, Mounjaro or Zepbound: what helps

Source: https://pepvault.app/guides/constipation-on-a-glp-1

Last updated: 2026-11-20

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Guides](https://pepvault.app/guides) [GLP-1s](https://pepvault.app/guides#glp1)

# Constipation on Ozempic, Mounjaro or Zepbound: how common, and what helps

Reviewed November 2026 13 sources [Published by PepVault](https://pepvault.app/guides/how-we-research)

Constipation on Ozempic, Wegovy, Mounjaro and Zepbound: each label's rate against placebo, when it starts, why it lasts for weeks, and what helps.

- **Last reviewed:** Nov 20, 2026
- **Sources:** 13
- **Questions:** 7
- **Compounds:** 3

## The short answer

Constipation affects about one in four people on Wegovy 2.4 mg (24% against 11% on placebo) and 11% to 17% on Zepbound (against 5%), fewer at the diabetes doses of Ozempic and Mounjaro. It starts early and, unlike diarrhea, lingers: an episode lasted a median of 47 days on semaglutide. Water, fiber from food and walking come first, then a laxative your prescriber or pharmacist suggests.

Every number checked at its primary source · Nov 20, 2026 · [13 sources](https://pepvault.app/guides/constipation-on-a-glp-1#sources) · [How we research](https://pepvault.app/guides/how-we-research)

**Evidence:** FDA prescribing information for all four medicines, built on randomized placebo-controlled trials in people; trial registry results from STEP 1, SURMOUNT-1 and SURMOUNT-5; a sponsor-funded pooled analysis of the STEP trials for timing and duration; three US health-record studies; and an expert consensus and a joint society advisory for the practical steps.

## How common is constipation on Ozempic, Wegovy, Mounjaro and Zepbound?

Common on all four, and far more common at the weight-loss doses. Ozempic and Wegovy are semaglutide; Mounjaro and Zepbound are tirzepatide. Each US label counts the share of people in its placebo-controlled trials who reported constipation at least once, set against a placebo group on a dummy shot[1](https://pepvault.app/guides/constipation-on-a-glp-1#source-1) [2](https://pepvault.app/guides/constipation-on-a-glp-1#source-2) [3](https://pepvault.app/guides/constipation-on-a-glp-1#source-3) [4](https://pepvault.app/guides/constipation-on-a-glp-1#source-4):

| Medicine and dose | Trials behind the number | Constipation on the drug | Constipation on placebo |
| --- | --- | --- | --- |
| Ozempic 0.5 mg | 2 type 2 diabetes trials, 32.9 weeks on average | 5% | 1.5% |
| Ozempic 1 mg | The same 2 trials | 3.1% | 1.5% |
| Mounjaro 5 mg | 2 type 2 diabetes trials, 36.6 weeks on average | 6% | 1% |
| Mounjaro 10 mg | The same 2 trials | 6% | 1% |
| Mounjaro 15 mg | The same 2 trials | 7% | 1% |
| Wegovy 2.4 mg | 3 weight trials, up to 68 weeks | 24% | 11% |
| Wegovy 7.2 mg (19% on its 2.4 mg arm) | 2 weight trials, 72 weeks | 20% | 8% |
| Zepbound 5 mg | 2 weight trials, up to 72 weeks | 17% | 5% |
| Zepbound 10 mg | The same 2 trials | 14% | 5% |
| Zepbound 15 mg | The same 2 trials | 11% | 5% |

Two things stand out. The weight doses add far more over placebo than the diabetes doses do. And on tirzepatide, constipation is the one stomach effect that falls as the dose rises: 17%, 14% and 11% on Zepbound[4](https://pepvault.app/guides/constipation-on-a-glp-1#source-4), and the same shape in SURMOUNT-1's registry results, 17.9%, 18.4% and 12.7% against 5.9% on placebo[9](https://pepvault.app/guides/constipation-on-a-glp-1#source-9). No source we found explains why. The labels warn that rates from different trials cannot be compared directly[1](https://pepvault.app/guides/constipation-on-a-glp-1#source-1) [3](https://pepvault.app/guides/constipation-on-a-glp-1#source-3). When both drugs ran in one 72-week trial (SURMOUNT-5), at their top weight doses or the highest each person tolerated, constipation was close to a tie: 27.0% on tirzepatide and 28.5% on semaglutide[10](https://pepvault.app/guides/constipation-on-a-glp-1#source-10).

The Wegovy pill (25 mg) had side effects of similar types and rates to the 2.4 mg shot. In teenagers on Wegovy, constipation affected 6% against 2% on placebo. Zepbound's count includes reports of hard stools[2](https://pepvault.app/guides/constipation-on-a-glp-1#source-2) [4](https://pepvault.app/guides/constipation-on-a-glp-1#source-4).

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

PepVault's dose log keeps each weekly shot with its date and the step-ups your prescriber set, as you enter them, so you can see which step a slow week followed.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## Why do health records show far less GLP-1 constipation than the trials?

Because they count different things. A trial asks everyone at every visit and counts any report, however mild. A health record counts what a doctor wrote down. In the US All of Us research program, 31.6% of 11,656 GLP-1 users had constipation in their records at some point, against 26.8% of non-users, all of them people with obesity: a high share, but most of it was not new[11](https://pepvault.app/guides/constipation-on-a-glp-1#source-11).

For constipation that was new after starting, the same study matched users to similar non-users. In the first year, GLP-1 users got a new constipation diagnosis at a rate of 3.34 per 100 person-years (person-years means people times years followed), a mean of 141 days after the first dose. The risk was about 1.5 times that of matched non-users. By drug, the rate was 2.90 on semaglutide and 1.81 on tirzepatide[11](https://pepvault.app/guides/constipation-on-a-glp-1#source-11). So constipation in the trials is common and mostly mild; constipation that reaches a doctor is a small minority.

## When does GLP-1 constipation start, and how long does it last?

It starts early and then holds steady, unlike nausea. In the pooled STEP 1 to 3 weight trials on semaglutide 2.4 mg, the share of people with constipation at any one time climbed and then levelled off at about week 10, while nausea, diarrhea and vomiting kept rising to a peak near week 20[5](https://pepvault.app/guides/constipation-on-a-glp-1#source-5). A Spanish expert panel's review puts the start in the first 16 weeks, particularly the first 28 days[6](https://pepvault.app/guides/constipation-on-a-glp-1#source-6).

The striking number is the length. Each episode was timed from start to end: the median, the middle value, was 47 days on semaglutide against 35 days on placebo, while diarrhea lasted 3 days and vomiting 2[5](https://pepvault.app/guides/constipation-on-a-glp-1#source-5). The registries show the other half of the pattern: few people had it again and again. We divided each trial's reported episodes by the number of people who had any[8](https://pepvault.app/guides/constipation-on-a-glp-1#source-8) [9](https://pepvault.app/guides/constipation-on-a-glp-1#source-9) [10](https://pepvault.app/guides/constipation-on-a-glp-1#source-10):

| Trial and group | People with constipation | Episodes reported | Episodes per person who had it (our division) |
| --- | --- | --- | --- |
| STEP 1, semaglutide 2.4 mg (75 weeks) | 305 of 1,306 (23.4%) | 389 | 1.3 |
| STEP 1, placebo | 62 of 655 (9.5%) | 73 | 1.2 |
| SURMOUNT-1, tirzepatide 5 mg (up to 193 weeks) | 113 of 630 (17.9%) | 129 | 1.1 |
| SURMOUNT-1, tirzepatide 10 mg | 117 of 636 (18.4%) | 148 | 1.3 |
| SURMOUNT-1, tirzepatide 15 mg | 80 of 630 (12.7%) | 100 | 1.3 |
| SURMOUNT-1, placebo | 38 of 643 (5.9%) | 49 | 1.3 |
| SURMOUNT-5, tirzepatide (72 weeks) | 101 of 374 (27.0%) | 179 | 1.8 |
| SURMOUNT-5, semaglutide | 107 of 376 (28.5%) | 167 | 1.6 |

So a person who got constipated had one or two episodes on average, about as many as on placebo; on the same STEP 1 count, diarrhea came about twice per person (our guide to diarrhea on a GLP-1 has those numbers). Read each trial on its own: the windows differ, and SURMOUNT-5 was open-label, so everyone knew which drug they took[10](https://pepvault.app/guides/constipation-on-a-glp-1#source-10). For people who stayed on semaglutide after a 20-week climb in STEP 4, constipation became less common over time[5](https://pepvault.app/guides/constipation-on-a-glp-1#source-5). No primary source we found gives an episode length for tirzepatide.

<!--promo-->

PepVault's dose log keeps each weekly shot with its date and the step-ups your prescriber set, as you enter them, so you can see which step a slow week followed. [Log it in PepVault](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-constipation-on-a-glp-1-inline&mt=8)

<!--/promo-->

## With this guide

### Semaglutide

- [Semaglutide: the full reference](https://pepvault.app/peptides/semaglutide)
- [Semaglutide dose guide](https://pepvault.app/lab/dosage/semaglutide)

### Tirzepatide

- [Tirzepatide: the full reference](https://pepvault.app/peptides/tirzepatide)
- [Tirzepatide dose guide](https://pepvault.app/lab/dosage/tirzepatide)

### Mixing charts

- [Semaglutide 2 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-2mg)
- [Semaglutide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-5mg)
- [Semaglutide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-10mg)
- [Tirzepatide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-5mg)
- [Tirzepatide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-10mg)
- [Tirzepatide 15 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-15mg)
- [Tirzepatide 30 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-30mg)
- [Tirzepatide 60 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-60mg)

### Studies

- [Semaglutide: 11.85% more weight loss than placebo without diabetes](https://pepvault.app/research/semaglutide-tan-2022)
- [CagriSema: 18.4% weight loss vs 11.9% on semaglutide in REDEFINE 5](https://pepvault.app/research/cagrisema-redefine-5-2026)
- [CagriSema: HbA1c down 2.33% at 40 weeks in REIMAGINE 3](https://pepvault.app/research/cagrisema-reimagine-3-2026)
- [All 31 studies](https://pepvault.app/research#semaglutide)
- [Tirzepatide plus apitegromab: 1.9 kg less lean mass loss in EMBRAZE](https://pepvault.app/research/tirzepatide-embraze-2026)
- [Tirzepatide SURMOUNT-MAINTAIN: 21.9% weight loss at 112 weeks](https://pepvault.app/research/tirzepatide-surmount-maintain-2026)
- [Dulaglutide: switching to tirzepatide beat dose escalation on HbA1c](https://pepvault.app/research/dulaglutide-surpass-switch-2025)
- [All 19 studies](https://pepvault.app/research#tirzepatide)

### Compared with

- [Semaglutide vs Tirzepatide](https://pepvault.app/peptides/compare/semaglutide-vs-tirzepatide)
- [Retatrutide vs Semaglutide](https://pepvault.app/peptides/compare/retatrutide-vs-semaglutide)
- [Orforglipron vs Semaglutide](https://pepvault.app/peptides/compare/orforglipron-vs-semaglutide)
- [Cagrilintide vs Semaglutide](https://pepvault.app/peptides/compare/cagrilintide-vs-semaglutide)
- [Liraglutide vs Semaglutide](https://pepvault.app/peptides/compare/liraglutide-vs-semaglutide)
- [Semaglutide vs Dulaglutide](https://pepvault.app/peptides/compare/semaglutide-vs-dulaglutide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)
- [GLP-1 titration planner](https://pepvault.app/tools/glp1-titration-calculator)
- [GLP-1 weight loss by week](https://pepvault.app/tools/glp1-weight-loss-by-week)

### The GLP-1 path

- [Retatrutide week by week](https://pepvault.app/guides/retatrutide-week-by-week)
- [Retatrutide dosage: the trial step-ups](https://pepvault.app/guides/retatrutide-dosage-in-trials)
- [Tirzepatide week by week](https://pepvault.app/guides/tirzepatide-week-by-week)
- [Semaglutide week by week](https://pepvault.app/guides/semaglutide-week-by-week)
- [Tirzepatide dosage: every step from 2.5 to 15 mg (Mounjaro and Zepbound)](https://pepvault.app/guides/tirzepatide-dosage)
- [Wegovy and Ozempic dosage: both labels' steps in one table, and why the two differ](https://pepvault.app/guides/wegovy-and-ozempic-dosage)
- [How to use the Zepbound KwikPen](https://pepvault.app/guides/how-to-use-the-zepbound-kwikpen)
- [How to use the Ozempic and Wegovy pens: needles, the dose counter and clicks](https://pepvault.app/guides/how-to-use-ozempic-and-wegovy-pens)
- [What time of day to take your GLP-1 shot or pill, and can you change the day?](https://pepvault.app/guides/when-to-take-your-glp-1)
- [Switching GLP-1s: Ozempic to Zepbound, shot to pill, and what the trials tested](https://pepvault.app/guides/switching-between-glp-1s)
- [Ozempic vs Wegovy vs Mounjaro vs Zepbound: the four labels in one table](https://pepvault.app/guides/ozempic-wegovy-mounjaro-zepbound)
- [Is Ozempic insulin? GLP-1, GIP and insulin explained](https://pepvault.app/guides/is-ozempic-insulin)
- [The Wegovy pill: what it is, how its label differs from the shot, and the trial numbers](https://pepvault.app/guides/the-wegovy-pill)
- [Ozempic and Wegovy side effects: what the trials counted and when they showed up](https://pepvault.app/guides/ozempic-and-wegovy-side-effects)
- [Semaglutide vs tirzepatide side effects: what the head-to-head trials found](https://pepvault.app/guides/sema-vs-tirzepatide-side-effects)
- [Microdosing a GLP-1: what it means and what has been tested](https://pepvault.app/guides/microdosing-a-glp-1)
- [GLP-1s and sleep apnea: Zepbound's OSA approval](https://pepvault.app/guides/glp-1-and-sleep-apnea)
- [Retatrutide first dose: the first four weeks in the trials](https://pepvault.app/guides/retatrutide-first-dose)
- [Retatrutide side effects: what the trials counted](https://pepvault.app/guides/retatrutide-side-effects)
- [Retatrutide not working? Stalls, slow responders and the plateau](https://pepvault.app/guides/retatrutide-not-working)
- [Switching from tirzepatide to retatrutide: what is known](https://pepvault.app/guides/tirzepatide-to-retatrutide)
- [Is retatrutide safe? What the trials reported](https://pepvault.app/guides/is-retatrutide-safe)
- [When will retatrutide be approved?](https://pepvault.app/guides/when-will-retatrutide-be-approved)
- [TRIUMPH-5 results: retatrutide vs tirzepatide head to head](https://pepvault.app/guides/triumph-5-results)
- [CagriSema FDA approval: when it's due, the dose filed, and what the trials showed](https://pepvault.app/guides/cagrisema-fda-decision)
- [MariTide phase 3 results (MARITIME-1): what to expect](https://pepvault.app/guides/maritime-1-results)
- [Aleniglipron: the GLP-1 pill, and the trial switching people from shots to it](https://pepvault.app/guides/aleniglipron-switch-trial)
- [Mounjaro and Zepbound side effects by dose: the rates at each step](https://pepvault.app/guides/mounjaro-zepbound-side-effects)
- [Hair loss on a GLP-1: how common it is per drug, and why](https://pepvault.app/guides/hair-loss-on-a-glp-1)
- ["Ozempic face": what it is, and where the weight comes from](https://pepvault.app/guides/ozempic-face)
- [Foundayo (orforglipron) vs the shots: the trial numbers side by side](https://pepvault.app/guides/foundayo-vs-the-shots)
- [Is compounded semaglutide or tirzepatide the same as Ozempic or Zepbound?](https://pepvault.app/guides/compounded-glp-1-vs-brand)
- [Why compounded semaglutide and tirzepatide come with B12, glycine or B6, and what it changes](https://pepvault.app/guides/compounded-glp-1-with-b12)
- [Is there a generic Ozempic? Generic semaglutide and Sevmia](https://pepvault.app/guides/generic-semaglutide)
- [How much does a GLP-1 cost in 2026? Zepbound, Wegovy and Medicare prices](https://pepvault.app/guides/how-much-does-a-glp-1-cost)
- [What to eat on a GLP-1: what the trials and the guidelines say](https://pepvault.app/guides/what-to-eat-on-a-glp-1)
- [How much protein per day? The numbers by weight and goal](https://pepvault.app/guides/how-much-protein-per-day)
- [Muscle on a GLP-1: how much of the weight lost is lean mass?](https://pepvault.app/guides/muscle-on-a-glp-1)
- [Intermittent fasting on a GLP-1: what the trials and labels say](https://pepvault.app/guides/intermittent-fasting-on-a-glp-1)
- [Coffee on a GLP-1: can you drink it, and why it can taste different](https://pepvault.app/guides/coffee-on-a-glp-1)
- [Food noise on a GLP-1: what it is and what happens after stopping](https://pepvault.app/guides/food-noise-on-a-glp-1)
- [GLP-1s and menopause: what the trials say about women in midlife](https://pepvault.app/guides/glp-1s-and-menopause)
- [Stopping a GLP-1: what happens to your weight](https://pepvault.app/guides/stopping-a-glp-1)
- [How to keep the weight off after a GLP-1: what each trial tested](https://pepvault.app/guides/keeping-weight-off-after-a-glp-1)
- [Berberine vs metformin vs a GLP-1: what each does to weight and glucose](https://pepvault.app/guides/berberine-vs-metformin-vs-glp-1)
- [Natural GLP-1 alternatives: what the evidence shows for berberine, fiber and supplements](https://pepvault.app/guides/natural-glp-1-alternatives)
- [What is 5-Amino-1MQ? What's been measured](https://pepvault.app/guides/5-amino-1mq-explained)
- [Retatrutide from a lab vial: what independent testing found](https://pepvault.app/guides/retatrutide-lab-vial-tests)
- [Switching from Saxenda to Wegovy: how the change works](https://pepvault.app/guides/saxenda-to-wegovy)
- [Do you stop Ozempic, Wegovy, Mounjaro or Zepbound before surgery?](https://pepvault.app/guides/glp-1-before-surgery)
- [Diarrhea on a GLP-1: how common, and how long it lasts](https://pepvault.app/guides/diarrhea-on-a-glp-1)
- [Dizziness on a GLP-1: dehydration, blood pressure or blood sugar?](https://pepvault.app/guides/dizziness-on-a-glp-1)
- [Heartburn and acid reflux on a GLP-1: the rates, the timing and what helps](https://pepvault.app/guides/heartburn-on-a-glp-1)
- [Does Ozempic or Mounjaro make you tired? Fatigue in the trials](https://pepvault.app/guides/glp-1-fatigue)
- [Can a GLP-1 cause low blood sugar if you do not have diabetes?](https://pepvault.app/guides/glp-1-low-blood-sugar)
- [Is there a medicine for GLP-1 nausea? Tradipitant, so far](https://pepvault.app/guides/tradipitant-for-glp-1-nausea)
- [GLP-1s and mood: depression, anxiety and what the FDA review found](https://pepvault.app/guides/glp-1s-and-mood)
- [Can Ozempic cause vision loss? GLP-1s and NAION, by the numbers](https://pepvault.app/guides/glp-1-and-naion)
- [Are GLP-1s safe long term? What the longest trials show](https://pepvault.app/guides/are-glp-1s-safe-long-term)
- [GLP-1s and the kidneys: what FLOW showed, and the dehydration risk](https://pepvault.app/guides/glp-1s-and-the-kidneys)
- [Can you drink alcohol on Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/alcohol-on-a-glp-1)
- [Do GLP-1s reduce alcohol cravings? What the trials found](https://pepvault.app/guides/glp-1-and-alcohol-cravings)
- [GLP-1s and fatty liver: what the trials measured](https://pepvault.app/guides/glp-1-and-fatty-liver)
- [GLP-1s after a gastric sleeve or bypass: regain, dosing and sleeve vs GLP-1](https://pepvault.app/guides/glp-1-after-bariatric-surgery)
- [Can you drink alcohol on retatrutide?](https://pepvault.app/guides/retatrutide-and-alcohol)
- [Ozempic, Wegovy, Mounjaro or Zepbound not working? Slow responders and plateaus in the trials](https://pepvault.app/guides/glp-1-not-working)
- [Intermittent fasting for weight and fat loss: what the trials measured](https://pepvault.app/guides/intermittent-fasting-weight-loss)
- [Can you take metformin with Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/metformin-with-a-glp-1)
- [GLP-1s and pregnancy: Ozempic, Wegovy, Mounjaro and Zepbound before and during](https://pepvault.app/guides/glp-1s-and-pregnancy)
- [Can you take Ozempic, Mounjaro or another GLP-1 while breastfeeding?](https://pepvault.app/guides/glp-1-while-breastfeeding)
- [Eloralintide, petrelintide and amycretin: the amylin drugs in trials](https://pepvault.app/guides/amylin-drugs-in-trials)
- [Olatorepatide (HS-20094): Regeneron's obesity drug, what is known so far](https://pepvault.app/guides/olatorepatide-explained)
- [Cagrilintide and CagriSema: what amylin adds to semaglutide](https://pepvault.app/guides/cagrilintide-and-cagrisema)
- [Berobenatide (PF-08653944, MET-097i): Pfizer's monthly GLP-1 shot, what is known so far](https://pepvault.app/guides/berobenatide-explained)
- [The GLP-1 pipeline: every drug in phase 2 and 3, and when its trials finish](https://pepvault.app/guides/glp-1-pipeline)
- [Is there a monthly GLP-1 shot? MariTide and berobenatide](https://pepvault.app/guides/monthly-glp-1-shots)
- [Cagrilintide alone: RENEW 1 phase 3 results and what to expect](https://pepvault.app/guides/renew-1-cagrilintide-results)
- [Wegovy HD: is 7.2 mg worth it, and what changes from 2.4 mg](https://pepvault.app/guides/wegovy-hd-7-2-mg)
- [Zenagamtide (amycretin): Novo's GLP-1 and amylin shot and pill, what the trials show](https://pepvault.app/guides/zenagamtide-amycretin)
- [Wegovy and Ozempic price, Medicare and WADA: what changes on January 1, 2027](https://pepvault.app/guides/glp-1-changes-january-2027)
- [Can you take sermorelin with Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/sermorelin-with-a-glp-1)
- [Retatrutide in women: what the studies included](https://pepvault.app/guides/retatrutide-in-women)
- [Peptides for women: what the trials in women show, and after 40](https://pepvault.app/guides/peptides-for-women)
- [Low-dose naltrexone (LDN) for weight loss: what the trials measured](https://pepvault.app/guides/ldn-for-weight-loss)
- [GLP-1s and PCOS: what the trials show, and how they compare with metformin](https://pepvault.app/guides/glp-1-and-pcos)
- [GLP-1s and sleep: insomnia, vivid dreams and the sleep apnea approval](https://pepvault.app/guides/glp-1s-and-sleep)
- [Nausea on Ozempic, Wegovy, Mounjaro or Zepbound: when it peaks and what helps](https://pepvault.app/guides/nausea-on-a-glp-1)
- [Headaches on a GLP-1: how common they were in the trials](https://pepvault.app/guides/headaches-on-a-glp-1)
- [Sulfur burps on Ozempic or Mounjaro: why they happen](https://pepvault.app/guides/sulfur-burps-on-a-glp-1)
- [GLP-1s and the gallbladder: gallstones, and taking one without a gallbladder](https://pepvault.app/guides/glp-1s-and-the-gallbladder)
- [GLP-1s and the heart: heart rate, blood pressure and the SELECT trial](https://pepvault.app/guides/glp-1s-and-the-heart)
- [Do GLP-1s cause cancer? The thyroid warning and what the studies show](https://pepvault.app/guides/do-glp-1s-cause-cancer)
- [Retatrutide and cancer: what the warning and the studies say](https://pepvault.app/guides/retatrutide-and-cancer)
- [Retatrutide and muscle loss: what the studies measured](https://pepvault.app/guides/retatrutide-and-muscle)

### Terms on this page

- [Stack](https://pepvault.app/glossary/stack)
- [GLP-1](https://pepvault.app/glossary/glp-1)
- [Placebo](https://pepvault.app/glossary/placebo)
- [Open-label](https://pepvault.app/glossary/open-label)

## Why do GLP-1s cause constipation?

All four labels state that the medicine slows how fast the stomach empties[1](https://pepvault.app/guides/constipation-on-a-glp-1#source-1) [2](https://pepvault.app/guides/constipation-on-a-glp-1#source-2) [3](https://pepvault.app/guides/constipation-on-a-glp-1#source-3) [4](https://pepvault.app/guides/constipation-on-a-glp-1#source-4). The STEP analysis's authors add that changes in how fast food moves through the lower gut may explain constipation, that the proof is still thin, and that constipation may last longer because of these drugs' effect on gut movement[5](https://pepvault.app/guides/constipation-on-a-glp-1#source-5).

Two everyday reasons stack on top. Feeling full for longer, people tend to drink less water, which the expert panel names as a cause[6](https://pepvault.app/guides/constipation-on-a-glp-1#source-6). And eating less means less going through: a joint advisory from four US lifestyle-medicine, nutrition and obesity societies calls constipation common with weight loss itself, and notes that meals high in protein or fat slow the stomach further[7](https://pepvault.app/guides/constipation-on-a-glp-1#source-7).

## Is constipation on a GLP-1 serious?

Rarely. In the STEP 1 to 3 trials, 98.1% of all stomach side effects on semaglutide 2.4 mg were mild or moderate and 99.5% were not serious[5](https://pepvault.app/guides/constipation-on-a-glp-1#source-5). Serious constipation was counted in 1 of 1,306 people on semaglutide in STEP 1[8](https://pepvault.app/guides/constipation-on-a-glp-1#source-8), and in 1 of 636 on tirzepatide 10 mg in SURMOUNT-1[9](https://pepvault.app/guides/constipation-on-a-glp-1#source-9).

After approval, all four labels list rare reports of ileus (the bowel stops moving), intestinal blockage and severe constipation with impacted stool[1](https://pepvault.app/guides/constipation-on-a-glp-1#source-1) [2](https://pepvault.app/guides/constipation-on-a-glp-1#source-2) [3](https://pepvault.app/guides/constipation-on-a-glp-1#source-3) [4](https://pepvault.app/guides/constipation-on-a-glp-1#source-4). In US insurance records of adults with type 2 diabetes, severe gut-motility problems of this kind ran at 1.02 per 100 person-years on GLP-1 medicines against 0.75 on another diabetes drug class, SGLT-2 inhibitors[12](https://pepvault.app/guides/constipation-on-a-glp-1#source-12). Among GLP-1 users with type 2 diabetes who started an opioid painkiller, 0.33% to 0.51% had severe constipation, a blockage or a stalled stomach within 30 days, highest on oxycodone[13](https://pepvault.app/guides/constipation-on-a-glp-1#source-13). Tell your prescriber about any painkiller you start.

## What helps with constipation on a GLP-1?

Fluids, fiber and movement first, from the first weeks. These come from the expert panel's recommendations and the joint advisory[6](https://pepvault.app/guides/constipation-on-a-glp-1#source-6) [7](https://pepvault.app/guides/constipation-on-a-glp-1#source-7):

1. Drink generous amounts of water or other sugar-free drinks through the day, even when you do not feel thirsty: fullness makes it easy to drink less.
2. Get enough fiber from food, and raise it gradually: prunes and other dried fruit, vegetables, beans and whole grains.
3. Lean on lighter, watery foods such as fruit and vegetables, which leave the stomach faster.
4. If it lingers, ease off very rich, fatty or protein-heavy meals for a while, since they slow the stomach further; spread your protein across the day rather than dropping it.
5. Walk or move more each day.
6. Keep a short diary of stools, food and dose to see whether it is easing.

When food is not enough, the advisory lists the next options: daily magnesium, adjusted to keep stools regular (magnesium citrate is the form it names), fiber supplements, polyethylene glycol 3350 (an over-the-counter laxative that holds water in the stool), and stool softeners to avoid straining[7](https://pepvault.app/guides/constipation-on-a-glp-1#source-7). Our guide to magnesium glycinate and citrate covers the forms. The panel adds that a lower GLP-1 dose is an option if it worsens[6](https://pepvault.app/guides/constipation-on-a-glp-1#source-6), the trials let people stay up to 8 weeks on a dose so stomach effects could settle[7](https://pepvault.app/guides/constipation-on-a-glp-1#source-7), and the Wegovy shot's label tells prescribers to consider waiting 4 more weeks before the next step if a dose is not tolerated[2](https://pepvault.app/guides/constipation-on-a-glp-1#source-2). The advisory also notes that some anti-nausea medicines, such as ondansetron, can worsen constipation[7](https://pepvault.app/guides/constipation-on-a-glp-1#source-7). Which laxative, and any dose change, is for your prescriber or pharmacist to decide.

**Commonly reported:** constipation is a regular theme in open write-ups; on our reports pages, 2 of 41 people on semaglutide and 5 of 77 on tirzepatide mentioned it.

**When to get help** The Medication Guides ask you to tell your prescriber about stomach problems that are severe or will not go away, and to stop the medicine and call right away for severe pain in the stomach area that will not go away, with or without vomiting[1](https://pepvault.app/guides/constipation-on-a-glp-1#source-1) [2](https://pepvault.app/guides/constipation-on-a-glp-1#source-2) [3](https://pepvault.app/guides/constipation-on-a-glp-1#source-3) [4](https://pepvault.app/guides/constipation-on-a-glp-1#source-4).

## How do I keep track of constipation on a GLP-1?

Note the day it starts, how strong it is, what you ate and drank, and which dose you were on. A few weeks of notes show whether it is easing, as it did for most people in the trials, or holding on, which is the pattern to bring to your prescriber.

<!--promo-->

PepVault's side-effect log records each symptom with the compound, a severity from minimal to very severe, the date and a note. On tirzepatide, constipation is one tap in the quick list. [Log it in PepVault](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-constipation-on-a-glp-1-inline&mt=8)

<!--/promo-->

<!--promo-->

PepVault's food log counts the fiber in each meal and shows the day's total against a daily fiber target set from your calorie target. [Track your food in PepVault](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-constipation-on-a-glp-1-inline&mt=8)

<!--/promo-->

The full side-effect picture for each medicine is in our guides to Ozempic and Wegovy side effects, Mounjaro and Zepbound side effects, and what to eat on a GLP-1.

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-card-next&mt=8)

<!--/promo-->

## Sources

1. OZEMPIC (semaglutide) injection prescribing information, DailyMed (SPL version 20; published on DailyMed June 10, 2026). Sections 6.1 (Table 1), 6.2, 7.2 and the Medication Guide. [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=adec4fd2-6858-4c99-91d4-531f5f2a2d79)
2. WEGOVY (semaglutide) injection and tablets prescribing information, DailyMed (SPL version 19; published on DailyMed June 30, 2026). Sections 2.2, 6.1 (Tables 3, 4 and 5), 6.2, 7 and the Medication Guide. [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b)
3. MOUNJARO (tirzepatide) injection prescribing information, DailyMed (SPL version 40; published on DailyMed September 2, 2026). Sections 6.1 (Table 1), 6.2, 7 and the Medication Guide. [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d2d7da5d-ad07-4228-955f-cf7e355c8cc0)
4. ZEPBOUND (tirzepatide) injection prescribing information, DailyMed (SPL version 40; published on DailyMed September 2, 2026). Sections 6.1 (Table 1), 6.2, 7 and the Medication Guide. [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b)
5. Wharton S et al. Gastrointestinal tolerability of once-weekly semaglutide 2.4 mg in adults with overweight or obesity, and the relationship between gastrointestinal adverse events and weight loss. Diabetes Obes Metab. 2022;24:94-105. [PubMed 34514682](https://pubmed.ncbi.nlm.nih.gov/34514682/)
6. Gorgojo-Martínez JJ et al. Clinical recommendations to manage gastrointestinal adverse events in patients treated with GLP-1 receptor agonists: a multidisciplinary expert consensus. J Clin Med. 2023;12:145. [PubMed 36614945](https://pubmed.ncbi.nlm.nih.gov/36614945/)
7. Mozaffarian D et al. Nutritional priorities to support GLP-1 therapy for obesity: a joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society. Obesity. 2025;33(8):1475-1503. [PubMed 40445127](https://pubmed.ncbi.nlm.nih.gov/40445127/)
8. ClinicalTrials.gov NCT03548935 (STEP 1; sponsor Novo Nordisk A/S). Results: adverse events, week 0 to 75. [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03548935)
9. ClinicalTrials.gov NCT04184622 (SURMOUNT-1; sponsor Eli Lilly and Company). Results: adverse events, baseline up to week 193. [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04184622)
10. ClinicalTrials.gov NCT05822830 (SURMOUNT-5; sponsor Eli Lilly and Company). Results: adverse events, baseline up to week 72. [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05822830)
11. Chang M, Wang K, Berschback M, Staller K. High prevalence and low incidence of constipation among glucagon-like peptide-1 receptor agonist users. Clin Gastroenterol Hepatol. 2026 (online June 2). [PubMed 42235870](https://pubmed.ncbi.nlm.nih.gov/42235870/)
12. Alkabbani W et al. Glucagon-like peptide-1 based therapies and the risk of severe gastrointestinal motility adverse events: a cohort study. Diabetes Obes Metab. 2026;28(8):7494-7504. [PubMed 42244136](https://pubmed.ncbi.nlm.nih.gov/42244136/)
13. Bea S et al. Comparative short-term risk of severe gastrointestinal events associated with opioid type among patients receiving glucagon-like peptide 1 receptor agonists. Diabetes Care. 2026;49(11):2050-2059. [PubMed 42684335](https://pubmed.ncbi.nlm.nih.gov/42684335/)

<!--promo-->

Newsletter · Weekly

## The weekly peptide briefing.

New guides, the week’s peptide news, one tool. Free, one email a week, unsubscribe anytime.

<!--/promo-->

## Next guide · GLP-1

Guide · GLP-1

### [Nausea on Ozempic, Wegovy, Mounjaro or Zepbound: when it peaks and what helps](https://pepvault.app/guides/nausea-on-a-glp-1)

Nausea on Ozempic, Wegovy, Mounjaro and Zepbound: each label's rate by dose against placebo, the week it peaks, how long a bout lasts and what helps.

Read the next guide

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

Log every dose, track every vial, and see your protocol come together.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## In the library

- [Semaglutide Studied range: 0.25–2.4 mg](https://pepvault.app/peptides/semaglutide)
- [Tirzepatide Studied range: 2.5–15 mg](https://pepvault.app/peptides/tirzepatide)
- [Semaglutide (oral) Studied range: 1.5–25 mg](https://pepvault.app/peptides/semaglutide-oral)

## Related guides

- Guide · GLP-1s

  ### [Diarrhea on a GLP-1: how common, and how long it lasts](https://pepvault.app/guides/diarrhea-on-a-glp-1)

  Diarrhea on Ozempic, Wegovy, Mounjaro and Zepbound: each label's rate by dose against placebo, when it starts, how long a bout lasts, and what helps.

  Read the guide
- Guide · GLP-1s

  ### [What to eat on a GLP-1: what the trials and the guidelines say](https://pepvault.app/guides/what-to-eat-on-a-glp-1)

  What to eat on Ozempic, Wegovy or Zepbound: protein first, small regular meals, fiber and fluids, what to limit, and what the trials' diet programmes asked for.

  Read the guide
- Guide · GLP-1s

  ### [Ozempic and Wegovy side effects: what the trials counted and when they showed up](https://pepvault.app/guides/ozempic-and-wegovy-side-effects)

  Ozempic and Wegovy side effects from the labels' trials, drug against placebo: nausea and the rest, when they start, how many days they last, and what helps.

  Read the guide
- Guide · GLP-1s

  ### [Mounjaro and Zepbound side effects by dose: the rates at each step](https://pepvault.app/guides/mounjaro-zepbound-side-effects)

  Mounjaro and Zepbound side effects at 5, 10 and 15 mg against placebo, from the labels' trial tables: when they show up, how many stopped, and what helps.

  Read the guide
- Guide · GLP-1s

  ### [Semaglutide vs tirzepatide side effects: what the head-to-head trials found](https://pepvault.app/guides/sema-vs-tirzepatide-side-effects)

  Semaglutide vs tirzepatide side effects in the same trials: nausea, vomiting, reflux, hair loss and injection-site rates side by side, and how many stopped.

  Read the guide
- Guide · Longevity and supplements

  ### [Magnesium glycinate vs citrate vs threonate: which form for what](https://pepvault.app/guides/magnesium-glycinate-vs-citrate)

  Magnesium glycinate vs citrate vs threonate: how much each is absorbed, which one the sleep and memory trials tested, what they found, and how to read a label.

  Read the guide

## Guides

- [All guides](https://pepvault.app/guides)
- [How we research](https://pepvault.app/guides/how-we-research)

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

Log every dose, track every vial, and see your protocol come together.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this guide

### Semaglutide

- [Semaglutide: the full reference](https://pepvault.app/peptides/semaglutide)
- [Semaglutide dose guide](https://pepvault.app/lab/dosage/semaglutide)

### Tirzepatide

- [Tirzepatide: the full reference](https://pepvault.app/peptides/tirzepatide)
- [Tirzepatide dose guide](https://pepvault.app/lab/dosage/tirzepatide)

### Mixing charts

- [Semaglutide 2 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-2mg)
- [Semaglutide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-5mg)
- [Semaglutide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-10mg)
- [Tirzepatide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-5mg)
- [Tirzepatide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-10mg)
- [Tirzepatide 15 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-15mg)
- [Tirzepatide 30 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-30mg)
- [Tirzepatide 60 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-60mg)

### Studies

- [Semaglutide: 11.85% more weight loss than placebo without diabetes](https://pepvault.app/research/semaglutide-tan-2022)
- [CagriSema: 18.4% weight loss vs 11.9% on semaglutide in REDEFINE 5](https://pepvault.app/research/cagrisema-redefine-5-2026)
- [CagriSema: HbA1c down 2.33% at 40 weeks in REIMAGINE 3](https://pepvault.app/research/cagrisema-reimagine-3-2026)
- [All 31 studies](https://pepvault.app/research#semaglutide)
- [Tirzepatide plus apitegromab: 1.9 kg less lean mass loss in EMBRAZE](https://pepvault.app/research/tirzepatide-embraze-2026)
- [Tirzepatide SURMOUNT-MAINTAIN: 21.9% weight loss at 112 weeks](https://pepvault.app/research/tirzepatide-surmount-maintain-2026)
- [Dulaglutide: switching to tirzepatide beat dose escalation on HbA1c](https://pepvault.app/research/dulaglutide-surpass-switch-2025)
- [All 19 studies](https://pepvault.app/research#tirzepatide)

### Compared with

- [Semaglutide vs Tirzepatide](https://pepvault.app/peptides/compare/semaglutide-vs-tirzepatide)
- [Retatrutide vs Semaglutide](https://pepvault.app/peptides/compare/retatrutide-vs-semaglutide)
- [Orforglipron vs Semaglutide](https://pepvault.app/peptides/compare/orforglipron-vs-semaglutide)
- [Cagrilintide vs Semaglutide](https://pepvault.app/peptides/compare/cagrilintide-vs-semaglutide)
- [Liraglutide vs Semaglutide](https://pepvault.app/peptides/compare/liraglutide-vs-semaglutide)
- [Semaglutide vs Dulaglutide](https://pepvault.app/peptides/compare/semaglutide-vs-dulaglutide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)
- [GLP-1 titration planner](https://pepvault.app/tools/glp1-titration-calculator)
- [GLP-1 weight loss by week](https://pepvault.app/tools/glp1-weight-loss-by-week)

### The GLP-1 path

- [Retatrutide week by week](https://pepvault.app/guides/retatrutide-week-by-week)
- [Retatrutide dosage: the trial step-ups](https://pepvault.app/guides/retatrutide-dosage-in-trials)
- [Tirzepatide week by week](https://pepvault.app/guides/tirzepatide-week-by-week)
- [Semaglutide week by week](https://pepvault.app/guides/semaglutide-week-by-week)
- [Tirzepatide dosage: every step from 2.5 to 15 mg (Mounjaro and Zepbound)](https://pepvault.app/guides/tirzepatide-dosage)
- [Wegovy and Ozempic dosage: both labels' steps in one table, and why the two differ](https://pepvault.app/guides/wegovy-and-ozempic-dosage)
- [How to use the Zepbound KwikPen](https://pepvault.app/guides/how-to-use-the-zepbound-kwikpen)
- [How to use the Ozempic and Wegovy pens: needles, the dose counter and clicks](https://pepvault.app/guides/how-to-use-ozempic-and-wegovy-pens)
- [What time of day to take your GLP-1 shot or pill, and can you change the day?](https://pepvault.app/guides/when-to-take-your-glp-1)
- [Switching GLP-1s: Ozempic to Zepbound, shot to pill, and what the trials tested](https://pepvault.app/guides/switching-between-glp-1s)
- [Ozempic vs Wegovy vs Mounjaro vs Zepbound: the four labels in one table](https://pepvault.app/guides/ozempic-wegovy-mounjaro-zepbound)
- [Is Ozempic insulin? GLP-1, GIP and insulin explained](https://pepvault.app/guides/is-ozempic-insulin)
- [The Wegovy pill: what it is, how its label differs from the shot, and the trial numbers](https://pepvault.app/guides/the-wegovy-pill)
- [Ozempic and Wegovy side effects: what the trials counted and when they showed up](https://pepvault.app/guides/ozempic-and-wegovy-side-effects)
- [Semaglutide vs tirzepatide side effects: what the head-to-head trials found](https://pepvault.app/guides/sema-vs-tirzepatide-side-effects)
- [Microdosing a GLP-1: what it means and what has been tested](https://pepvault.app/guides/microdosing-a-glp-1)
- [GLP-1s and sleep apnea: Zepbound's OSA approval](https://pepvault.app/guides/glp-1-and-sleep-apnea)
- [Retatrutide first dose: the first four weeks in the trials](https://pepvault.app/guides/retatrutide-first-dose)
- [Retatrutide side effects: what the trials counted](https://pepvault.app/guides/retatrutide-side-effects)
- [Retatrutide not working? Stalls, slow responders and the plateau](https://pepvault.app/guides/retatrutide-not-working)
- [Switching from tirzepatide to retatrutide: what is known](https://pepvault.app/guides/tirzepatide-to-retatrutide)
- [Is retatrutide safe? What the trials reported](https://pepvault.app/guides/is-retatrutide-safe)
- [When will retatrutide be approved?](https://pepvault.app/guides/when-will-retatrutide-be-approved)
- [TRIUMPH-5 results: retatrutide vs tirzepatide head to head](https://pepvault.app/guides/triumph-5-results)
- [CagriSema FDA approval: when it's due, the dose filed, and what the trials showed](https://pepvault.app/guides/cagrisema-fda-decision)
- [MariTide phase 3 results (MARITIME-1): what to expect](https://pepvault.app/guides/maritime-1-results)
- [Aleniglipron: the GLP-1 pill, and the trial switching people from shots to it](https://pepvault.app/guides/aleniglipron-switch-trial)
- [Mounjaro and Zepbound side effects by dose: the rates at each step](https://pepvault.app/guides/mounjaro-zepbound-side-effects)
- [Hair loss on a GLP-1: how common it is per drug, and why](https://pepvault.app/guides/hair-loss-on-a-glp-1)
- ["Ozempic face": what it is, and where the weight comes from](https://pepvault.app/guides/ozempic-face)
- [Foundayo (orforglipron) vs the shots: the trial numbers side by side](https://pepvault.app/guides/foundayo-vs-the-shots)
- [Is compounded semaglutide or tirzepatide the same as Ozempic or Zepbound?](https://pepvault.app/guides/compounded-glp-1-vs-brand)
- [Why compounded semaglutide and tirzepatide come with B12, glycine or B6, and what it changes](https://pepvault.app/guides/compounded-glp-1-with-b12)
- [Is there a generic Ozempic? Generic semaglutide and Sevmia](https://pepvault.app/guides/generic-semaglutide)
- [How much does a GLP-1 cost in 2026? Zepbound, Wegovy and Medicare prices](https://pepvault.app/guides/how-much-does-a-glp-1-cost)
- [What to eat on a GLP-1: what the trials and the guidelines say](https://pepvault.app/guides/what-to-eat-on-a-glp-1)
- [How much protein per day? The numbers by weight and goal](https://pepvault.app/guides/how-much-protein-per-day)
- [Muscle on a GLP-1: how much of the weight lost is lean mass?](https://pepvault.app/guides/muscle-on-a-glp-1)
- [Intermittent fasting on a GLP-1: what the trials and labels say](https://pepvault.app/guides/intermittent-fasting-on-a-glp-1)
- [Coffee on a GLP-1: can you drink it, and why it can taste different](https://pepvault.app/guides/coffee-on-a-glp-1)
- [Food noise on a GLP-1: what it is and what happens after stopping](https://pepvault.app/guides/food-noise-on-a-glp-1)
- [GLP-1s and menopause: what the trials say about women in midlife](https://pepvault.app/guides/glp-1s-and-menopause)
- [Stopping a GLP-1: what happens to your weight](https://pepvault.app/guides/stopping-a-glp-1)
- [How to keep the weight off after a GLP-1: what each trial tested](https://pepvault.app/guides/keeping-weight-off-after-a-glp-1)
- [Berberine vs metformin vs a GLP-1: what each does to weight and glucose](https://pepvault.app/guides/berberine-vs-metformin-vs-glp-1)
- [Natural GLP-1 alternatives: what the evidence shows for berberine, fiber and supplements](https://pepvault.app/guides/natural-glp-1-alternatives)
- [What is 5-Amino-1MQ? What's been measured](https://pepvault.app/guides/5-amino-1mq-explained)
- [Retatrutide from a lab vial: what independent testing found](https://pepvault.app/guides/retatrutide-lab-vial-tests)
- [Switching from Saxenda to Wegovy: how the change works](https://pepvault.app/guides/saxenda-to-wegovy)
- [Do you stop Ozempic, Wegovy, Mounjaro or Zepbound before surgery?](https://pepvault.app/guides/glp-1-before-surgery)
- [Diarrhea on a GLP-1: how common, and how long it lasts](https://pepvault.app/guides/diarrhea-on-a-glp-1)
- [Dizziness on a GLP-1: dehydration, blood pressure or blood sugar?](https://pepvault.app/guides/dizziness-on-a-glp-1)
- [Heartburn and acid reflux on a GLP-1: the rates, the timing and what helps](https://pepvault.app/guides/heartburn-on-a-glp-1)
- [Does Ozempic or Mounjaro make you tired? Fatigue in the trials](https://pepvault.app/guides/glp-1-fatigue)
- [Can a GLP-1 cause low blood sugar if you do not have diabetes?](https://pepvault.app/guides/glp-1-low-blood-sugar)
- [Is there a medicine for GLP-1 nausea? Tradipitant, so far](https://pepvault.app/guides/tradipitant-for-glp-1-nausea)
- [GLP-1s and mood: depression, anxiety and what the FDA review found](https://pepvault.app/guides/glp-1s-and-mood)
- [Can Ozempic cause vision loss? GLP-1s and NAION, by the numbers](https://pepvault.app/guides/glp-1-and-naion)
- [Are GLP-1s safe long term? What the longest trials show](https://pepvault.app/guides/are-glp-1s-safe-long-term)
- [GLP-1s and the kidneys: what FLOW showed, and the dehydration risk](https://pepvault.app/guides/glp-1s-and-the-kidneys)
- [Can you drink alcohol on Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/alcohol-on-a-glp-1)
- [Do GLP-1s reduce alcohol cravings? What the trials found](https://pepvault.app/guides/glp-1-and-alcohol-cravings)
- [GLP-1s and fatty liver: what the trials measured](https://pepvault.app/guides/glp-1-and-fatty-liver)
- [GLP-1s after a gastric sleeve or bypass: regain, dosing and sleeve vs GLP-1](https://pepvault.app/guides/glp-1-after-bariatric-surgery)
- [Can you drink alcohol on retatrutide?](https://pepvault.app/guides/retatrutide-and-alcohol)
- [Ozempic, Wegovy, Mounjaro or Zepbound not working? Slow responders and plateaus in the trials](https://pepvault.app/guides/glp-1-not-working)
- [Intermittent fasting for weight and fat loss: what the trials measured](https://pepvault.app/guides/intermittent-fasting-weight-loss)
- [Can you take metformin with Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/metformin-with-a-glp-1)
- [GLP-1s and pregnancy: Ozempic, Wegovy, Mounjaro and Zepbound before and during](https://pepvault.app/guides/glp-1s-and-pregnancy)
- [Can you take Ozempic, Mounjaro or another GLP-1 while breastfeeding?](https://pepvault.app/guides/glp-1-while-breastfeeding)
- [Eloralintide, petrelintide and amycretin: the amylin drugs in trials](https://pepvault.app/guides/amylin-drugs-in-trials)
- [Olatorepatide (HS-20094): Regeneron's obesity drug, what is known so far](https://pepvault.app/guides/olatorepatide-explained)
- [Cagrilintide and CagriSema: what amylin adds to semaglutide](https://pepvault.app/guides/cagrilintide-and-cagrisema)
- [Berobenatide (PF-08653944, MET-097i): Pfizer's monthly GLP-1 shot, what is known so far](https://pepvault.app/guides/berobenatide-explained)
- [The GLP-1 pipeline: every drug in phase 2 and 3, and when its trials finish](https://pepvault.app/guides/glp-1-pipeline)
- [Is there a monthly GLP-1 shot? MariTide and berobenatide](https://pepvault.app/guides/monthly-glp-1-shots)
- [Cagrilintide alone: RENEW 1 phase 3 results and what to expect](https://pepvault.app/guides/renew-1-cagrilintide-results)
- [Wegovy HD: is 7.2 mg worth it, and what changes from 2.4 mg](https://pepvault.app/guides/wegovy-hd-7-2-mg)
- [Zenagamtide (amycretin): Novo's GLP-1 and amylin shot and pill, what the trials show](https://pepvault.app/guides/zenagamtide-amycretin)
- [Wegovy and Ozempic price, Medicare and WADA: what changes on January 1, 2027](https://pepvault.app/guides/glp-1-changes-january-2027)
- [Can you take sermorelin with Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/sermorelin-with-a-glp-1)
- [Retatrutide in women: what the studies included](https://pepvault.app/guides/retatrutide-in-women)
- [Peptides for women: what the trials in women show, and after 40](https://pepvault.app/guides/peptides-for-women)
- [Low-dose naltrexone (LDN) for weight loss: what the trials measured](https://pepvault.app/guides/ldn-for-weight-loss)
- [GLP-1s and PCOS: what the trials show, and how they compare with metformin](https://pepvault.app/guides/glp-1-and-pcos)
- [GLP-1s and sleep: insomnia, vivid dreams and the sleep apnea approval](https://pepvault.app/guides/glp-1s-and-sleep)
- [Nausea on Ozempic, Wegovy, Mounjaro or Zepbound: when it peaks and what helps](https://pepvault.app/guides/nausea-on-a-glp-1)
- [Headaches on a GLP-1: how common they were in the trials](https://pepvault.app/guides/headaches-on-a-glp-1)
- [Sulfur burps on Ozempic or Mounjaro: why they happen](https://pepvault.app/guides/sulfur-burps-on-a-glp-1)
- [GLP-1s and the gallbladder: gallstones, and taking one without a gallbladder](https://pepvault.app/guides/glp-1s-and-the-gallbladder)
- [GLP-1s and the heart: heart rate, blood pressure and the SELECT trial](https://pepvault.app/guides/glp-1s-and-the-heart)
- [Do GLP-1s cause cancer? The thyroid warning and what the studies show](https://pepvault.app/guides/do-glp-1s-cause-cancer)
- [Retatrutide and cancer: what the warning and the studies say](https://pepvault.app/guides/retatrutide-and-cancer)
- [Retatrutide and muscle loss: what the studies measured](https://pepvault.app/guides/retatrutide-and-muscle)

### Terms on this page

- [Stack](https://pepvault.app/glossary/stack)
- [GLP-1](https://pepvault.app/glossary/glp-1)
- [Placebo](https://pepvault.app/glossary/placebo)
- [Open-label](https://pepvault.app/glossary/open-label)

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

Log every dose, track every vial, and see your protocol come together.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
